Compare DV & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DV | LMAT |
|---|---|---|
| Founded | 2008 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2021 | 2006 |
| Metric | DV | LMAT |
|---|---|---|
| Price | $13.49 | $79.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 8 |
| Target Price | $13.48 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 3.1M | 203.6K |
| Earning Date | 11-06-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.24% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | 0.12 | ★ 1.42 |
| Revenue | ★ $748,291,000.00 | $249,602,000.00 |
| Revenue This Year | $7.78 | $10.79 |
| Revenue Next Year | $8.34 | $9.54 |
| P/E Ratio | $112.42 | ★ $57.12 |
| Revenue Growth | ★ 13.92 | 13.53 |
| 52 Week Low | $7.61 | $78.22 |
| 52 Week High | $13.65 | $118.01 |
| Indicator | DV | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 66.62 | 41.33 |
| Support Level | $13.32 | $78.56 |
| Resistance Level | $13.65 | $83.08 |
| Average True Range (ATR) | 0.04 | 1.89 |
| MACD | -0.03 | 0.28 |
| Stochastic Oscillator | 85.71 | 23.80 |
DoubleVerify Holdings Inc is a media effectiveness platform that leverages artificial intelligence (AI) to drive superior outcomes for international brands by creating transparent ad transactions. Its solutions provide unbiased data analytics to improve the effectiveness, quality and return on advertising investments. DV Authentic Ad is its proprietary metric measuring whether an ad was delivered in a brand suitable environment, fully viewable, by a real person and in geography, while DV Pinnacle delivers these metrics in real time. The Company's solutions are integrated across programmatic platforms, social media channels and digital publishers, and are accredited by the Media Rating Council for digital ad measurement. It operates in the United States and international markets.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.